65,437 trials
Hepatitis C · Alcohol Use Disorder
Primary: Changes in Neuropsychological Assessment Battery (NAB) Attention Module Scores — 10.99; 0.31; 6.35 Units on a scale
Osteoarthritis, Knee
Primary: Stage A: Number of Participants Achieving 30% Improvement From Baseline in Western Ontario and McMasters Arthritis Index (WOMAC) Pain Score — 26; 28; 38; 53 Participants
Hyperphagia in Prader-Willi Syndrome
Primary: Change From Baseline in Hyperphagia in Prader-Willi Syndrome (PWS) Questionnaires- Responsiveness (HPWSQ-R) Total Score at End-of-treatment (Day 15) — -15.6; -8.9 score…
Myopia
Primary: Visual Acuity — -0.07; -0.13 logMAR
Nephrolithiasis
Primary: Visual Analog Scale (VAS) Pain Scores — 4.5; 5; 1; 1 score on a scale
Communication
Primary: Satisfaction With Decision Making (Percentage of "Excellent" Scores in the Decision Making Domain of the Pediatric Family Satisfaction in the Intensive Care Unit…
Human Immunodeficiency Virus
Primary: Change From Baseline in Plasma HIV-1 Ribonucleic Acid (RNA) — -1.38; -1.40; -0.80 HIV-1 RNA copies/mL
Macular Telangiectasia Type 2
Primary: Frequency of Ocular and/or Non-ocular Treatment Emergent Adverse Events — 26; 26; 6; 13 Participants
Ophthalmopathy, Thyroid-Associated
Primary: Clinical Activity Score (a Composite Measure of Ophthalmological Signs and Symptoms) — 4.25; 2.77; 4.25; 4.20 score on a scale
Tooth, Impacted
Primary: Number of Definitive Upper Canines That Erupt Spontaneously up to 18 Months of Follow up — 3; 2; 1; 4 number of canines
Pancreatic Cancer
Primary: Treatment Response — 0; 0; 0; 0 participants
Secondary Peritonitis
Primary: Peritonitis Resolved — 26; 29 participants — p=<0.05
PTSD
Primary: PTSD Symptoms — 39.3; 38.6; 40.5 units on a scale
Parkinson Disease
Primary: Walking Activity — -207.59; -135.24 change in average daily steps — p=.89
Cataract
Primary: Monocular Uncorrected Distance Visual Acuity (6m) — 0.06 logMAR